This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
At the same time, the growing prevalence of complex cardiovascular conditions means assessing more nuanced, multifaceted presentations of heartdisease. Heres a look at how AI ultrasound and other tech innovations are helping cardiologists work faster while driving better outcomes for patients.
What does the future of heartdisease detection look like? He also discusses how this innovative solution is not just advancing diagnostic precision but also reshaping the way healthcare providers approach heartdisease treatment and patient care.
Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heartdisease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular HeartDisease?
milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heartdisease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. We are proud to support healthcare professionals personalize patients' heart health journeys.
milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , This procedure was carried out at the Narayana Hrudayalaya Institute of Cardiac Sciences in Bengaluru, India, and represents a milestone in the treatment of heartdisease using the SSi Mantra Surgical Robotic System. from 2022 to 2031.
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heartdisease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.
Researchers unveiled BeatProfiler, a groundbreaking new tool -- a comprehensive software that automates the analysis of heart cell function from video data.
These are true innovators who propose novel approaches to major research challenges in the areas of heartdisease, stroke and brain health. Loscalzo’s research will focus on the link between heartdisease and certain foods, or chemicals naturally contained in foods. Tsao , Ph.D.,
Getty Images milla1cf Tue, 01/16/2024 - 14:11 January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heartdisease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heartdisease diagnosis and treatment. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heartdisease in more detail.
a med tech company dedicated to helping patients with persistent ischemic heartdisease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain. T45 Labs is a specialized medical technology innovation company located in Santa Clara, Silicon Valley, CA.
The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.
Cleerly is dedicated to creating a new standard of care for heartdisease by using FDA-cleared solutions powered by artificial intelligence. With this investment, we look forward to helping Cleerly expand its reach and impact, bringing this potentially life-saving innovation to more patients and health systems nationally.
The adoption of the latest robotic magnetic navigation system represents our continued commitment to pursuing the innovative technologies and techniques that benefit our patients.” “For
Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heartdisease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.
Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. BackgroundIdentification of children with latent rheumatic heartdisease (RHD) by echocardiography, before onset of symptoms, provides an opportunity to initiate secondary prophylaxis and prevent disease progression.
The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.
25 saw a deluge of pharmaceutical solutions across the spectrum of heartdisease, from HCM all the way to LDL (detection and treatment just have to catch up). Among dozens of highlights, here are Cardiac Wires seven biggest trends from ACC.25. Diverse Pharma ACC.25
Physician Workforce Data Dashboard, only about 17% of cardiologists are women, ranking as one of the lowest specialties among female physicians, yet heartdisease remains the number one killer of women, accounting for one in five female deaths.
Background While research on congenital heartdisease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenital heartdisease in the Arab world from 1997 to 2022.
Access to Cutting-Edge Techniques Many fellowships expose participants to the latest technologies and innovations in their field. These programs also prepare fellows for leadership roles, equipping them to drive change and innovation in their respective fields. When to Pursue a Fellowship? Here are some scenarios to consider: 1.
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Incentives Prompt Increased Daily Walking in Patients at Risk for HeartDisease 6. Here is a look at what DAIC viewers were reading last month: 1. Novel CT Exam Reduces Need for Invasive Artery Treatment 7.
It’s a celebration of the amazing innovation that has occurred in structural heartdisease therapy over the last 20 years and I’m proud to be part of it. “Andreas Grüntzig was a pioneer in the field, so I’m grateful and honored to receive the Ethica Award,” said Dr. St.
According to the 2024 HeartDisease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association , heartdisease has been the leading cause of death in the U.S. s first Allia IGS Pulse system at Heart Hospital of New Mexico,” said Brian Miller , chief executive officer of HHNM*. “As
Within the complex umbrella of cardiovascular disease, CAD is a type of heartdisease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.
Medtronic is proud to support the incoming cohort of dynamic structural heartdisease specialists to the CTR REACH program,” said Jeffrey Popma , M.D., vice president and chief medical officer for the Coronary & Renal Denervation business and the Structural Heart & Aortic business at Medtronic.
The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases. Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management.
Attendees can join with their peers and participate in sessions on structural heartdisease, congenital heartdisease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heartdisease, debates and games and early career topics.
Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.
mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heartdisease, said Matthew J. The results from theEKSTROM trial offer powerful evidence thatlow-dose colchicine (0.5 Budoff, M.D.,
The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heartdisease.
Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heartdisease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. TEE helps cardiologists by providing highly detailed images of the heart and its internal structures.
February 1, 2024 — As cardiologists, heartdisease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.
With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD). It is currently undergoing clinical studies in the U.S.
BACKGROUND:Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.
In fact, only 1% of health care research and innovation was invested in female-specific conditions outside of oncology, according to the most recent data available. [1] In 1924, the physicians who founded the American Heart Association believed that better understanding of heartdisease would lead to better outcomes.
At present, machine learning, deep learning, and other AI technologies have been tried to be applied to intelligent diagnostic and decision making, image interpretation, accurate classification, and prognostication of cardiovascular diseases, which has led to broad application prospects and innovation potential.
Cardiovascular disease ( CVD ) is the leading cause of death globally, and the prevalence is expected to continue rising as people live longer and the population increases.1 Of these, approximately 30 are AI-enabled ultrasound innovations.
associate professor of biomedical research and translational medicine and scientific operations director at MMRI , recently published an innovative manuscript titled, Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Post-Myocardial Infarction. McCarthy, Ph.D.
Unfortunately, public funding has not kept pace with the burden of disease or rates of inflation. As the nations oldest and largest volunteer organization dedicated to fighting heartdisease and stroke, research is critical to the American Heart Associations mission.
Meanwhile, traditional methods for cardiac detection still rely on reactive, symptom-driven interventions that often catch heartdisease too late, when treatment is complex, critical and costly. AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions.
By expanding our HeartRisk platform, we're not just innovating within traditional healthcare sectors but breaking new ground in diverse markets. The complexity of providing care in correctional facilities is exacerbated by resource constraints and the difficulty of providing specialized care for heartdisease without transportation.
He added, “Adding Story Health to our ecosystem both allows providers to exceed their care quality goals and ensures patients aren’t waiting to receive ongoing care, especially between visits when they may have higher disease burden or complications that can lead to expensive emergency department visits.
This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content